OrphanDrug
OrphanDrug
Pharma Knowledge Base

autosomal dominant nonsyndromic deafness 22

ORPHA: 228012

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Classification & Codes

Overview

autosomal dominant nonsyndromic deafness that is characterized by postlingual onset with high frequency progressive hearing loss and has material basis in mutation in the MYO6 gene on chromosome 6q14

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Classification & Codes

Orphanet Code

ORPHA:228012
autosomal dominant nonsyndromic deafness 22
OrphanetORPHA:228012
Treatments0 drug(s)
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO